Quinoline 3 -sulfonate esters as nk3 receptor modulators

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 215/52 (2006.01) A61K 31/47 (2006.01) A61P 3/04 (2006.01) A61P 11/06 (2006.01) A61P 25/00 (2006.01) A61P 25/18 (2006.01) A61P 25/22 (2006.01) A61P 25/24 (2006.01) A61P 25/28 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2613001

Compounds of Formula I wherein R1, A, R2, R3, R4, R5 n, m and q are as described in the specification, pharmaceutically-acceptable salts, methods of making, pharmaceutical compositions containing and methods for using the same.

La présente invention décrit des composés de Formule I où R1, A, R2, R3, R4, R5, n, m et q sont tels que définis dans la description de l'invention, des sels de qualité pharmaceutique, des méthodes de fabrication, des préparations pharmaceutiques contenant lesdits composés ainsi que leurs méthodes d'utilisation.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Quinoline 3 -sulfonate esters as nk3 receptor modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Quinoline 3 -sulfonate esters as nk3 receptor modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinoline 3 -sulfonate esters as nk3 receptor modulators will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1839623

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.